Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  PAREXEL International Corporation    PRXL

PAREXEL INTERNATIONAL CORPORATION (PRXL)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCompany 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Business Summary
Logo PAREXEL International Corp
Provides clinical research and development services

PAREXEL International Corp. provides biopharmaceutical services.

It offers high-quality Phase I-IV clinical research, regulatory, consulting and market access solutions.

The company was founded by Josef H. von Rickenbach and Anne B. Sayigh in 1983 and is headquartered in Waltham, MA.
Managers
NameAgeSinceTitle
D. Jamie MacDonald492018Chief Executive Officer
Mark A. Goldberg, MD581997President & Chief Operating Officer
Josef H. von Rickenbach, MBA631983Chairman
Simon John Harford, MBA572017Chief Financial Officer & Senior Vice President
Sy Pretorius MD, MBA48-Chief Scientific Officer & Senior Vice President
Jeremy Gelber, PhD-2017Director
Mark Stephenson--Vice President-Global Corporate Communications
Gadi Saarony502003Senior Vice President-Clinical Research Services
Roland Andersson, PhD54-Senior Vice President-Clinical Research Services
David J. Godwin, MBA--Senior Vice President-Global Business Development
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 51,115,310 50,131,867 98.1% 0 0.0% 98.1%
Company contact information
PAREXEL International Corp.
195 West Street
Waltham, MA 02451

Phone : +1.781.487.9900
Fax : +1.781.487.0525
Web : www.parexel.com
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
PAREXEL INTERNATIONAL CORPORATION0.00%0
CELLTRION, INC.--.--%33 349
IQVIA HOLDINGS INC6.98%21 424
LONZA GROUP2.35%20 530
INCYTE CORPORATION-22.94%15 692
SEATTLE GENETICS, INC.22.95%10 577
ALNYLAM PHARMACEUTICALS, INC.-17.99%10 474
NEKTAR THERAPEUTICS-2.60%9 059
QIAGEN NV6.08%8 462
EXACT SCIENCES CORPORATION31.96%8 086
ICON PLC22.18%7 371
SAGE THERAPEUTICS INC-6.83%7 138
ALKERMES PLC-6.16%6 842
PRA HEALTH SCIENCES INC4.56%6 101
BIO-TECHNE CORP25.82%6 067
CHARLES RIVER LABORATORIES INTL. INC5.74%5 568
FIBROGEN INC37.03%5 425
IONIS PHARMACEUTICALS INC-14.61%5 391
UNITED THERAPEUTICS CORPORATION-21.28%5 072
FOUNDATION MEDICINE INC100.44%5 063
GALAPAGOS7.27%5 058
Connections : PAREXEL International Corp
Pamplona Capital Management LLP
Boston Millennia Partners
Intensity Therapeutics, Inc.
New England Healthcare Institute
Harvard T.H. Chan School of Public Health
PAREXEL International Ltd.
PAREXEL Informatics, Inc.
© 2018 People , Fundamentals and Ownership